Cargando…

Study of NGEP expression in androgen sensitive prostate cancer cells: A potential target for immunotherapy

Background: Prostate cancer is one of the leading causes of cancer deaths among men. New gene expressed in prostate (NGEP), is a prostate-specific gene expressed only in normal prostate and prostate cancer tissue. Because of its selective expression in prostate cancer cell surface, NGEP is a potenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohsenzadegan, Monireh, Tajik, Nader, Madjd, Zahra, Shekarabi, Mehdi, Farajollahi, Mohammad M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iran University of Medical Sciences 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431361/ https://www.ncbi.nlm.nih.gov/pubmed/26000254

Ejemplares similares

Development of dendritic cell loaded MAGE-A2 long peptide; a potential target for tumor-specific T cell-mediated prostate cancer immunotherapy
por: Bakhshi, Parisa, et al.
Publicado: (2023)

In-vitro prostate cancer biomarker detection by directed conjugation of anti-PSCA antibody to super paramagnetic iron oxide nanoparticless
por: Shahrabi Farahani, Mahboube, et al.
Publicado: (2019)

Epitope Prediction by Novel Immunoinformatics Approach: A State-of-the-art Review
por: Raoufi, Ehsan, et al.
Publicado: (2019)

Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer
por: Mohsenzadegan, Monireh, et al.
Publicado: (2022)

Publisher Correction: Co-expression of cancer-testis antigens of MAGE-A6 and MAGE-A11 is associated with tumor aggressiveness in patients with bladder cancer
por: Mohsenzadegan, Monireh, et al.
Publicado: (2022)

Fabrication of Antibody Conjugated Super Magnetic Oxide Nanoparticles for Early Detection of Prostate Cancer
por: Nayerpour dizaj, Tina, et al.
Publicado: (2023)

Designing and developing a sensitive and specific SARS-CoV-2 RBD IgG detection kit for identifying positive human samples
por: Raoufi, Ehsan, et al.
Publicado: (2023)

Impact of COVID-19 pandemic on screening and diagnosis of patients with prostate cancer: a systematic review protocol
por: Mostafavi Zadeh, Seyed Mostafa, et al.
Publicado: (2022)

IL‐1β Is an Androgen‐Responsive Target in Macrophages for Immunotherapy of Prostate Cancer
por: Wang, Deng, et al.
Publicado: (2023)

Differentially Expressed Androgen-Regulated Genes in Androgen-Sensitive Tissues Reveal Potential Biomarkers of Early Prostate Cancer
por: Altintas, Dogus Murat, et al.
Publicado: (2013)

Early results from a multi-component French public-private partnership initiative to improve participation in clinical research – CeNGEPS: a prospective before-after study
por: Bordet, Régis, et al.
Publicado: (2015)

CpG Immunotherapy in Chenopodium album sensitized mice: The comparison of IFN-gamma, IL-10 and IgE responses in intranasal and subcutaneous administrations
por: Mousavi, Tahereh, et al.
Publicado: (2008)

A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells
por: Li, Tzu-Huey, et al.
Publicado: (2007)

Clinical significance of peripheral blood CD11b(+)/CD33(+)/HLA-DR(-) myeloid cells in infants and children with infectious diseases and increased CRP
por: Latifi, Aysan, et al.
Publicado: (2020)

Combination of androgen receptor inhibitor enzalutamide with the CDK4/6 inhibitor ribociclib in triple negative breast cancer cells
por: Choupani, Edris, et al.
Publicado: (2022)

Androgen receptor signaling is required for androgen-sensitive human prostate cancer cell proliferation and survival
por: Yang, Qing, et al.
Publicado: (2005)

Immune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy
por: Kalina, Jennifer L., et al.
Publicado: (2017)

Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer
por: Kohli, Manish, et al.
Publicado: (2012)

Oncogenic functions and clinical significances of DCLK1 isoforms in colorectal cancer: a systematic review and meta-analysis
por: Kalantari, Elham, et al.
Publicado: (2022)

High expression of TROP2 characterizes different cell subpopulations in androgen-sensitive and androgen-independent prostate cancer cells
por: Xie, Jinhan, et al.
Publicado: (2016)

Circulating exosomal microRNAs as potential prognostic biomarkers in gastrointestinal cancers: a systematic review and meta-analysis
por: Gheytanchi, Elmira, et al.
Publicado: (2023)

Metformin and Androgen Receptor-Axis-Targeted (ARAT) Agents Induce Two PARP-1-Dependent Cell Death Pathways in Androgen-Sensitive Human Prostate Cancer Cells
por: Xie, Yi, et al.
Publicado: (2021)

The effects of probiotic supplement on hemoglobin in chronic renal failure patients under hemodialysis: A randomized clinical trial
por: Shariaty, Zahra, et al.
Publicado: (2017)

Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease
por: Samaee, Hamidreza, et al.
Publicado: (2020)

Tumor-derived exosomes: the next generation of promising cell-free vaccines in cancer immunotherapy
por: Naseri, Marzieh, et al.
Publicado: (2020)

Melatonin decreases androgen-sensitive prostate cancer growth by suppressing SENP1 expression
por: Hao, Lin, et al.
Publicado: (2022)

Addition of androgen receptor-targeted agents to androgen-deprivation therapy and docetaxel in metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis
por: Maiorano, B.A., et al.
Publicado: (2022)

The Evolution of Prostate Cancer Therapy: Targeting the Androgen Receptor
por: Aragon-Ching, Jeanny B.
Publicado: (2014)

The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells
por: Seif, Farhad, et al.
Publicado: (2017)

Nuclear overexpression of DNA damage-inducible transcript 4 (DDIT4) is associated with aggressive tumor behavior in patients with pancreatic tumors
por: Tajik, Fatemeh, et al.
Publicado: (2023)

Potential Application of Novel DNA Editing Techniques in Translational Neuroscience
por: Shekarabi, Masoud
Publicado: (2015)

Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer
por: Obinata, Daisuke, et al.
Publicado: (2017)

Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients
por: Mu, L J, et al.
Publicado: (2005)

The established chemokine-related prognostic gene signature in prostate cancer: Implications for anti-androgen and immunotherapies
por: Chen, Lei, et al.
Publicado: (2022)

Androgens and prostate disease
por: Cooper, Lori A, et al.
Publicado: (2014)

Microfluidic-Based Mechanical Phenotyping of Androgen-Sensitive and Non-sensitive Prostate Cancer Cells Lines
por: Liu, Na, et al.
Publicado: (2019)

Treatment of prostate cancer: therapeutic potential of targeted immunotherapy with APC8015
por: Bok, Robert A
Publicado: (2008)

Epigenetics-related genes in prostate cancer: Expression profile in prostate cancer tissues, androgen-sensitive and -insensitive cell lines
por: ADLER, DAVID, et al.
Publicado: (2012)

Identification of novel androgen receptor target genes in prostate cancer
por: Jariwala, Unnati, et al.
Publicado: (2007)

Overview on the complexity of androgen receptor-targeted therapy for prostate cancer
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4ecj1ah941q6705h088nv2buv9